-1.png)
Via practica 3/2012
New treatment for postmenopausal osteoporosis
The overview article brings information on the new antiporotic drugs for postmenopausal osteoporosis. It deals with intravenous bisphosphonates – ibandronate and zoledronate, with new biological drug denosumab blocking RANKL and finally with osteoanabolic derivates of parathormon 1–34 and 1–84 PTH.
Keywords: osteoporosis, treatment, undesirable side effects.
